Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailINTERRATER AGREEMENT OF CLINICAL TESTS/SIGNS USED TO IDENTIFY PATIENTS WITH LUMBAR FUNCTIONAL INSTABILITY
Demoulin, Christophe ULg; Emmanuel, P.; DISTREE, Vincent ULg et al

in Journal of Orthopaedic & Sports Physical Therapy (2012, October), 42(10), 57

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailInterregional correlation of cerebral glucose metabolism in unmedicated schizophrenia
Biver, Françoise; Goldman, Serge; De Maertelaer, Viviane et al

in European Neuropsychopharmacology (1996), 6(2), 141-147

To investigate metabolic relationships between different brain regions in schizophrenia, we measured regional brain metabolism using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) in ... [more ▼]

To investigate metabolic relationships between different brain regions in schizophrenia, we measured regional brain metabolism using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) in 15 unmedicated schizophrenic patients and 15 healthy subjects. We analyzed correlations between glucose metabolism data of multiple brain regions using factorial analysis and correlation coefficient comparisons. Absolute regional intercorrelations in schizophrenic brains were found to be significantly stronger than in controls, in relationship to the greater variability of metabolic rates in schizophrenic patients. Variability of normalized metabolic rates and regional intercorrelations were not significantly different between schizophrenic patients and control subjects. We conclude that a global metabolic factor accounts for the variability of metabolic data in untreated schizophrenia. [less ▲]

Detailed reference viewed: 21 (1 ULg)
Full Text
See detailInterregionalism and emerging powers
Santander, Sébastian ULg

Scientific conference (2012, April 05)

La communication analyse les rapport entre le phénomène interrégional et les puissances émergentes.

Detailed reference viewed: 32 (2 ULg)
Full Text
Peer Reviewed
See detailEl interregionalismo europeo y la integración latinoamericana
Parra Santamaria, Lusmiriam Andrea ULg

in Entramado (2010), 12(juillet-décembre),

The relationship between the EU and the Latin-American region belongs to the logics of interregionalism. This article approaches this relation especially in what the Latin-American integration is ... [more ▼]

The relationship between the EU and the Latin-American region belongs to the logics of interregionalism. This article approaches this relation especially in what the Latin-American integration is concerned. In this way, in a first moment, a conceptual panorama (from the academic implications of region, regionalism and interregionalism, among others) is offered. By the means of the documentary method, the existence of an EU’s interregional strategy and its possible Americanization was verified. The obtained results showed: the existence of the UE interregional strategy as well as its concretization in the negotiation of the Free Trade Agreement (FTA) EU – CAN. The two major conclusions of this article were: First, there is a slight Americanization of this interregional European strategy. The second conclusion is that a deepening of the international presence of Europe as regional actor is observed. It means the deepening of the EU’s soft power. [less ▲]

Detailed reference viewed: 63 (5 ULg)
Full Text
Peer Reviewed
See detailInterrelations genetique- environnement: la broncho-pneumopathie chronique obstructive.
Corhay, Jean-Louis ULg; Frusch, Nicolas; LOUIS, Renaud ULg

in Revue Médicale de Liège (2012), 67(5-6), 292-7

Smoking is the main environmental risk factor of COPD and accounts for 85% to 90% of COPD. However, 10-15% of COPD patients have never smoked and only a fraction of smokers ever develop COPD. Indeed ... [more ▼]

Smoking is the main environmental risk factor of COPD and accounts for 85% to 90% of COPD. However, 10-15% of COPD patients have never smoked and only a fraction of smokers ever develop COPD. Indeed, genetic and environmental (pollution, occupational and infectious) factors, also influence the risk of developing COPD. Finaly COPD must be considered as the clinical consequence of multiple complex interactions between environmental factors and genetic susceptibility. The latter is not clearly understood, with the exception of alpha-1 antitrypsin deficiency. In this article, we present the different aspects of this complex disease which is primarily environmental. [less ▲]

Detailed reference viewed: 25 (6 ULg)
Full Text
Peer Reviewed
See detailInterrelationship of Hypertension, Plasma Lipids and Atherosclerosis
Krzesinski, Jean-Marie ULg; Carlier, P. G.; Rorive, G. L.

in Drugs (1988), 36(Suppl 2), 18-26

The relationship between hypertension and atherosclerosis has been illustrated by epidemiological, clinical and experimental observations. Typical atherosclerotic lesions develop in arterial wall when ... [more ▼]

The relationship between hypertension and atherosclerosis has been illustrated by epidemiological, clinical and experimental observations. Typical atherosclerotic lesions develop in arterial wall when hypercholesterolaemia is present. Hypertension aggravates these lesions by causing vascular structural changes. In clinical studies, however, the correction of high blood pressure does not decrease the incidence of coronary heart disease. Several hypotheses have been formulated to account for this observation: one is that reversibility of the structural vascular changes induced by hypertension is not complete when the blood pressure is lowered; another is that antihypertensive drugs have a deleterious effect on the vascular wall. [less ▲]

Detailed reference viewed: 20 (1 ULg)
Full Text
Peer Reviewed
See detailInterruption médicamenteuse pré-anesthésique: état actuel de la question
Wolfs, C.; Sottiaux, Thierry; Lamy, Maurice ULg

in Revue Médicale de Liège (1981), XXXVI(5), 185-193

Detailed reference viewed: 11 (2 ULg)
Full Text
Peer Reviewed
See detailInterruption of antiretroviral therapy is associated with increased plasma cystatin C.
Mocroft, Amanda; Wyatt, Christina; Szczech, Lynda et al

in AIDS (2009), 23(1), 71-82

BACKGROUND: Cystatin C has been proposed as an alternative marker of renal function. We sought to determine whether participants randomized to episodic use of antiretroviral therapy guided by CD4 cell ... [more ▼]

BACKGROUND: Cystatin C has been proposed as an alternative marker of renal function. We sought to determine whether participants randomized to episodic use of antiretroviral therapy guided by CD4 cell count (drug conservation) had altered cystatin C levels compared with those randomized to continuous antiretroviral therapy (viral suppression) in the Strategies for Management of Antiretroviral Therapy trial, and to identify factors associated with increased cystatin C. METHODS: Cystatin C was measured in plasma collected at randomization, 1, 2, 4, 8 and 12 months after randomization in a random sample of 249 and 250 participants in the drug conservation and viral suppression groups, respectively. Logistic regression was used to model the odds of at least 0.15 mg/dl increase in cystatin C (1 SD) in the first month after randomization, adjusting for demographic and clinical characteristics. RESULTS: At randomization, mean (SD) cystatin C level was 0.99 (0.26 mg/dl) and 1.01 (0.28 mg/dl) in the drug conservation and viral suppression arms, respectively (P = 0.29). In the first month after randomization, 21.8 and 10.6% had at least 0.15 mg/dl increase in cystatin C in the drug conservation and viral suppression arms, respectively (P = 0.0008). The difference in cystatin C between the treatment arms was maintained through 1 year after randomization. After adjustment, participants in the viral suppression arm had significantly reduced odds of at least 0.15 mg/dl increase in cystatin C in the first month (odds ratio 0.42; 95% confidence interval 0.23-0.74, P = 0.0023). CONCLUSION: These results demonstrate that interruption of antiretroviral therapy is associated with an increase in cystatin C, which may reflect worsened renal function. [less ▲]

Detailed reference viewed: 17 (3 ULg)
Full Text
Peer Reviewed
See detailInterruption prematuree des etudes ASCOT et CARDS de prevention cardio-vasculaire avec l'atorvastatine chez le sujet hypertendu ou diabetique: compromis entre ethique et statistique en medecine factuelle.
Scheen, André ULg

in Revue Médicale de Liège (2003), 58(9), 585-90

The Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA), performed in hypertensive patients with coronary risk and the Collaborative AtoRvastatin Diabetes Study (CARDS), performed in ... [more ▼]

The Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA), performed in hypertensive patients with coronary risk and the Collaborative AtoRvastatin Diabetes Study (CARDS), performed in diabetic patients, also at coronary risk, were prematurely stopped, at the special request of the Data Safety Monitoring Board. Indeed, an interim analysis demonstrated the efficacy of atorvastatin, at a daily dosage of 10 mg as compared to placebo, in the prevention of major cardiovascular events, so that it appeared unethical to continue the study until the end. At the glance of these observations, the ethical and statistical aspects of such prevention clinical trials are discussed, in particular when the premature interruption of the ongoing study appears mandatory, with respect of the main rules of evidence-based medicine. [less ▲]

Detailed reference viewed: 21 (0 ULg)
Full Text
Peer Reviewed
See detailL'interscripteur et le rhapsode
Servais, Christine ULg

in Parouty-David, Françoise; Zilberberg, Claude (Eds.) Sémiotique et esthétique (2003)

Detailed reference viewed: 24 (4 ULg)
Full Text
Peer Reviewed
See detailLes intersémiotiques
Badir, Sémir ULg

in Estudos Semióticos (2013), 9(1), 1-12

Detailed reference viewed: 10 (0 ULg)